| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | Sep 16, 2024 | Option Exercise | $6.36 | 661 | 4,204 | 53,919 | Sep 17, 2024, 05:12 PM | |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | Feb 13, 2024 | Option Exercise | $6.53 | 1,735 | 11,330 | 25,030 | Feb 15, 2024, 05:03 PM | |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | Aug 30, 2023 | Option Exercise | $2.93 | 661 | 1,937 | 26,765 | Aug 31, 2023, 04:09 PM | |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | Jan 30, 2023 | Option Exercise | $7.78 | 1,222 | 9,507 | 5,176 | Feb 01, 2023, 04:10 PM | |
| CCCC | C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | May 26, 2022 | Option Exercise | $7.01 | 1,102 | 7,725 | 2,648 | Jun 14, 2022, 04:45 PM |
Menu